4.8 Article

Single-cell and spatial analysis reveal interaction of FAP+ fibroblasts and SPP1+ macrophages in colorectal cancer

Journal

NATURE COMMUNICATIONS
Volume 13, Issue 1, Pages -

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41467-022-29366-6

Keywords

-

Funding

  1. National Key Research and Development Program of China [2021YFA1301400]
  2. National Natural Science Foundation of China [82073145, 31930035, 91942311, 81971487]
  3. Shanghai Science and Technology Commission [20JC1410100]
  4. Shanghai Pujiang Program [20PJ1412800]
  5. Natural Science Foundation of Shanghai [20ZR1472900]

Ask authors/readers for more resources

This study provides insights into the interaction between FAP(+) fibroblasts and SPP1(+) macrophages in colorectal cancer, suggesting a potential therapeutic strategy to improve immunotherapy by disrupting this interaction.
Tumour microenvironment profiling during colorectal cancer progression may enable the discovery of therapeutic targets. Here, single cell and spatial RNA sequencing of tumour and adjacent normal tissues reveals an interaction between FAP(+) fibroblasts and SPP1(+) macrophages that could be disrupted as an immunotherapy strategy. Colorectal cancer (CRC) is among the most common malignancies with limited treatments other than surgery. The tumor microenvironment (TME) profiling enables the discovery of potential therapeutic targets. Here, we profile 54,103 cells from tumor and adjacent tissues to characterize cellular composition and elucidate the potential origin and regulation of tumor-enriched cell types in CRC. We demonstrate that the tumor-specific FAP(+) fibroblasts and SPP1(+) macrophages were positively correlated in 14 independent CRC cohorts containing 2550 samples and validate their close localization by immuno-fluorescent staining and spatial transcriptomics. This interaction might be regulated by chemerin, TGF-beta, and interleukin-1, which would stimulate the formation of immune-excluded desmoplasic structure and limit the T cell infiltration. Furthermore, we find patients with high FAP or SPP1 expression achieved less therapeutic benefit from an anti-PD-L1 therapy cohort. Our results provide a potential therapeutic strategy by disrupting FAP(+) fibroblasts and SPP1(+) macrophages interaction to improve immunotherapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available